Allergan reported net sales of $1,467.4 million for the second quarter, up by 4.8 percent from the year-ago period, in spite of the strong U.S. dollar. On a constant-currency basis, the rate of increase was 8.7 percent. Sales of specialty pharmaceuticals grew by 5 percent, or 8.8 percent on a ...
Buying a membership today will give you:
To continue reading this article register now.